Stockscreener 앱 받기
4.18
0.95%
-0.04
전일 마감가:
$4.22
열려 있는:
$4.22
하루 거래량:
982.66K
Relative Volume:
0.34
시가총액:
$519.51M
수익:
$44.55M
순이익/손실:
$-83.78M
주가수익비율:
-5.3769
EPS:
-0.7774
순현금흐름:
$-52.99M
1주 성능:
+2.20%
1개월 성능:
+1.21%
6개월 성능:
-30.33%
1년 성능:
+47.70%
1일 변동 폭
$4.13
$4.29
1주일 범위
$4.015
$4.29
52주 변동 폭
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
명칭
Aquestive Therapeutics Inc
전화
908-941-1900
주소
30 TECHNOLOGY DRIVE, WARREN, NJ
Compare AQST vs TAK, ZTS, TEVA, HLN, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
4.18 | 519.51M | 44.55M | -83.78M | -52.99M | -0.7774 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.28B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.33B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.76B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 40.70B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.28B | 3.18B | 1.33B | 1.04B | 27.90 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-24 | 재개 | Oppenheimer | Outperform |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-10 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Piper Sandler | Overweight |
| 2024-03-28 | 개시 | Raymond James | Outperform |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2019-04-22 | 개시 | H.C. Wainwright | Buy |
| 2019-01-03 | 개시 | Lake Street | Buy |
| 2018-08-20 | 개시 | JMP Securities | Mkt Outperform |
| 2018-08-20 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Aquestive Therapeutics Inc 주식(AQST)의 최신 뉴스
AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - Barchart.com
MSN Money - MSN
AQST FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - New Castle News
Bronstein, Gewirtz & Grossman LLC Urges Aquestive - GlobeNewswire
AQST DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionAQST - TMX Newsfile
Will Aquestive Therapeutics (AQST) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
Press releases provided by CNW - Techaeris
aqst-pressreleasefinalx8.htm - SEC.gov
AQST Deadline: AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - Tullahoma News
AQST DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionAQST - ACCESS Newswire
AQST DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Aquestive Therapeutics, Inc. Investors to Join the Class Action Lawsuit Today - ACCESS Newswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Frau - The National Law Review
AQST DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aquestive Therapeutics, Inc. Investors ... - Caledonian Record
AQST DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action – AQST - GlobeNewswire Inc.
AQST DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionAQST - ACCESS Newswire
AQST DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionAQST - ACCESS Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
AQST Technical Analysis | Trend, Signals & Chart Patterns | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAQST - ChartMill
symbol__ Stock Quote Price and Forecast - CNN
AQST DEADLINE ALERT: ROSEN, A Top Ranked Law Firm, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionAQST - ACCESS Newswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Claims Pattern Of Harm: SueWallSt – Company AnnouncementFT.com - Financial Times
AQST Stockholders Have Opportunity to Lead Aquestive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fra - GuruFocus
AQST Shareholders Have Opportunity to Lead Aquestive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, - GlobeNewswire
AQST DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionAQST - TMX Newsfile
AQST Price Today: Aquestive Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST - ChartMill
AQST Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aquestive Therapeutics, Inc. Securities LawsuitContact The Gross Law Firm - PR Newswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
AQST Shareholder Alert: Investors With Losses May Seek to Lead t - GuruFocus
AQST DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionAQST - TMX Newsfile
AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. - GlobeNewswire
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - PR Newswire
AQST SEC FilingsAquestive Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
AQST DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionAQST - TMX Newsfile
Aquestive Therapeutics Stock Is Rising Pre-Market – Its $75M Funding Agreement Draws Divided Opinions From Retail - MSN
AQST DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Aquestive ... - Black Hills Pioneer
AQST DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionAQST - ACCESS Newswire
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQST DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionAQST - TMX Newsfile
Aquestive Therapeutics, Inc. (NASDAQ: AQST) Investor Alert: Deadline in Lawsuit on May 4, 2026 - openPR.com
[ARS] Aquestive Therapeutics, Inc. SEC Filing - Stock Titan
Aquestive (NASDAQ: AQST) maps 2026 votes on board, pay and auditor - Stock Titan
Oppenheimer Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Oppenheimer Initiates Coverage on Aquestive Therapeutics (NASDAQ:AQST) - MarketBeat
AQST Shareholder Alert: Aquestive Therapeutics, Inc. - GlobeNewswire
Aquestive Therapeutics Inc (AQST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
2.13%
자본화:
|
볼륨(24시간):